Hydroxy Urea
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Hydroxy Urea Product Information
Hydroxy Urea is listed under Intermediate and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Fluorouracil. The product is supplied by Clearsynth under CAT No. CS-T-28915.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Hydroxy Urea
CAS No.
127-07-1
CAT No.
CS-T-28915
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
CH4N2O2
Molecular Weight
76.1
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Hydroxy Urea is supplied with detailed characterization data compliant with regulatory guideline. Hydroxy Urea can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Fluorouracil.
Overview
An anti-neoplastic - inhibits ribonucleoside reductase and DNA replication. A potential therapy for sickle cell anemia which involves the nitrosylation of sickle cell hemoglobin. Horseradish peroxidase catalyzes nitric oxide formation from hydroxyurea in the presence of hydrogen peroxide.
Synonyms
Hydroxy Urea
Application Notes
An anti-neoplastic - inhibits ribonucleoside reductase and DNA replication. A potential therapy for sickle cell anemia which involves the nitrosylation of sickle cell hemoglobin. Horseradish peroxidase catalyzes nitric oxide formation from hydroxyurea in the presence of hydrogen peroxide.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.